Organigram Global to Acquire Aurora Cannabis for CA$7.80 per Common Share
Organigram Global (OGI) and Aurora Cannabis (ACB) agreed to a merger. Organigram will acquire Aurora for CA$7.80 per share. The deal is subject to regulatory approvals and shareholder votes.
How this was made

The 30-second read
Why it matters
For the target, the offer price is the primary near-term driver. For the acquirer, the market will weigh strategic rationale against integration and closing risks.
Market read
This is a headline M&A deal term that typically triggers immediate repricing and deal-arbitrage positioning in both buyer and target shares.
What to watch
Traders will need deal conditions, expected closing timeline, and any financing structure details, which are not present in the provided body excerpt.
Background
The article headline states Organigram Global and Aurora Cannabis entered an arrangement agreement for a cash acquisition at CA$7.80 per common share.
Market effects
Could shift sentiment across Canadian cannabis M&A, signaling consolidation and potential revaluation of distressed peers.
Most direct impact is on Canadian-listed cannabis equities and deal-arbitrage flows in Canada.
Limited global spillover beyond cannabis M&A expectations unless the deal changes broader industry financing conditions.
Counterpoint
Offer price may already be partially priced in, and deal risk (financing, regulatory approvals, shareholder votes) could cap upside or increase volatility.
Key entities
- acquirerOrganigram Global
Named as the buyer in an arrangement agreement to acquire Aurora Cannabis.
- targetAurora Cannabis
Named as the company to be acquired under the arrangement agreement.



